Early findings suggest a protein associated with Alzheimer's disease could potentially be used to identify Chronic Traumatic Encephalopathy (CTE), a brain condition linked to head trauma, while individuals are still alive.
A hallmark of Alzheimer’s disease, this protein may also serve as an indicator for CTE, according to recent research. Currently, CTE can only be definitively diagnosed post-mortem through examination of brain tissue. This presents a significant challenge in understanding and addressing the condition in living individuals, particularly those involved in contact sports where head injuries are common.
The findings suggest that detecting this protein could offer a way to identify CTE during a person’s lifetime. The research is still preliminary, but it opens up possibilities for earlier diagnosis and potential interventions. This is crucial because CTE is associated with repetitive brain trauma and can lead to various cognitive and behavioral issues.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy